Leonardo Hotel (Leaderboard Ad)

Let's Talk

Your Total Guide To lifestyle

Immune Checkpoint Inhibitors in Oncology Study Day

A hybrid oncology education study day in Manchester covering immune checkpoint inhibitors, including selection, biomarkers and toxicity management.

Immune Checkpoint Inhibitors in Oncology Study Day

A hybrid study day providing an update on immune checkpoint inhibitors (PD-1, PD-L1 and CTLA-4 inhibitors) across tumour types, including how they work, who they are for, and recognising/managing toxicity safely and effectively.

Date & time: Tuesday 24 November 2026, 9:00am – 5:00pm

Location: The Christie Institute for Cancer Education, 550 Wilmslow Road (Department 17), Manchester

Intended audience: Healthcare professionals involved in treating patients on immunotherapy, academics in cancer research, and others with an interest in this area.

Topics include:

  • Immune checkpoint inhibitor selection and biomarkers
  • ICIs across tumour types
  • Early immune-related adverse events
  • Late and long-term irAEs
  • Complex and rare immune-related toxicities and management
  • Combination ICI therapy
  • Nursing the ICI patient and patient safety

Venue accessibility (as listed): Lift access; accessible toilet; hearing loop; ramp access; prayer room available.



BOOK NOW
Tuesday 24 November 2026

The Christie institute for cancer education, 550 Wilmslow Road, Department 17, Manchester

Price: £50 - £375.12

From 9.00am Until 5.00pm

550 Wilmslow Road
Manchester
M20 4BX

The Christie NHS Foundation Trust

W: christie.nhs.uk

T: 0161 446 3000

The Christie NHS Foundation Trust

550 Wilmslow Road, Manchester, M20 4BX

Ask Agency (Animated Ad)

Weather in Manchester

Update cookies preferences